IPO - Iterum Therapeutics plc

Form Type: 424B5

Filing Date: 2025-04-30

Corporate Action: Ipo

Type: New

Accession Number: 000119312525105141

Filing Summary: On April 30, 2025, Iterum Therapeutics plc is proceeding with a public offering of 3,040,000 ordinary shares at a price of $0.90 per share, along with 2,515,556 pre-funded warrants, which allows some institutional investors to purchase ordinary shares without exceeding a certain ownership threshold. The offering is intended to raise funds for working capital and operational purposes. The total gross proceeds from the offering are expected to be approximately $4,974,844.84, with net proceeds anticipated to be about $4,599,844.81 after placement agent fees. The pre-funded warrants, issued at $0.89 each, have an exercise price of $0.01 per share and are fully exercisable upon issuance. This offering indicates the company's efforts to support the commercialization of their antibiotic product, ORLYNVAH, while also addressing their ongoing financial needs amid concerns about going concern status. The liquidity of the pre-funded warrants is expected to be extremely limited, as there is no intention to list them on any exchange.